Canvas Wealth Advisors’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Canvas Wealth Advisors's BMY Position: Q3 2026 in Review
Canvas Wealth Advisors increased its Bristol-Myers Squibb (BMY) stake by 17% in Q3 2026, buying an estimated $47.9K and bringing the position to 5,312 shares worth $326K. The position accounts for 0.04% of the portfolio, ranked #181.
Canvas Wealth Advisors first reported a position in BMY in Q1 2026 and has held it in 3 quarters since. 2,569 funds tracked by Wall St. Rank hold BMY as of Q3 2026.
- Canvas Wealth Advisors held 5,312 shares of Bristol-Myers Squibb worth $326K as of Q3 2026.
- Canvas Wealth Advisors bought 758 Bristol-Myers Squibb shares in Q3 2026, an estimated $47.9K.
- Bristol-Myers Squibb made up 0.04% of Canvas Wealth Advisors's portfolio in Q3 2026, its #181 holding.
- Canvas Wealth Advisors first reported a position in Bristol-Myers Squibb in Q1 2026 and has held it in 3 quarters since.
- 2,569 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2026.
Based on Canvas Wealth Advisors's 13F filing for Q3 2026, filed 2 Nov 2026.